136 related articles for article (PubMed ID: 29464)
1. Conditions for production of thermosensitive attenuated influenza virus recombinants.
Polezhaev FI; Garmashova LM; Polyakov YM; Golubev DB; Aleksandrova GI
Acta Virol; 1978 Jul; 22(4):263-9. PubMed ID: 29464
[TBL] [Abstract][Full Text] [Related]
2. Peculiarities of obtaining attenuated thermosensitive recombinants of influenza A virus at the end of the H3N2 epidemic cycle.
Polezhaev FI; Garmashova LM; Rumovsky VI; Aleksandrova GI; Smorodintsev AA
Acta Virol; 1980 Jun; 24(4):273-8. PubMed ID: 6106378
[TBL] [Abstract][Full Text] [Related]
3. Attenuated ts-recombinants of influenza A/USSR/77 (H1N1) virus obtained by crossing with the cold-adapted donor A/Leningrad/134/57 (H2N2) virus.
Polezhaev FI; Garmashova LM; Koval TA; Taranova GP; Topuriya NV; Aleksandrova GI
Acta Virol; 1982 Jul; 26(4):221-6. PubMed ID: 6127928
[TBL] [Abstract][Full Text] [Related]
4. Studies on some genetic properties of antigenic recombinants of influenza viruses.
Podchernyaeva RYa ; Döhner L; Herrmann RM; Blinova VK; Ivanova VT
Acta Virol; 1982 Jul; 26(4):227-33. PubMed ID: 6127929
[TBL] [Abstract][Full Text] [Related]
5. Attenuated influenza B virus recombinants obtained by crossing of B/England/2608/76 virus with a cold-adapted B/Leningrad/14/17/55 strain.
Medvedeva TE; Gordon MA; Ghendon YZ; Klimov AI; Alexandrova GI
Acta Virol; 1983 Jul; 27(4):311-7. PubMed ID: 6195900
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of influenza A/Victoria/3/75-ts-1 [E] recombinant viruses for attenuation and immunogenicity in adult seronegative volunteers.
Murphy BR; Markoff LJ; Chanock RM; Douglas RG; Betts RF; Cate TR; Couch RB
Dev Biol Stand; 1977 Jun 1-3; 39():47-52. PubMed ID: 604132
[No Abstract] [Full Text] [Related]
8. Influenza.
Sabin AB
Dev Biol Stand; 1976; 33():127-40. PubMed ID: 955265
[TBL] [Abstract][Full Text] [Related]
9. [Experience in selecting safe heat-sensitive influenza virus A recombinants].
Aleksandrova GI; Garmashova LM; Golubev DB; Koliak LI; Medvedeva TE
Vopr Virusol; 1979; (4):342-6. PubMed ID: 483771
[TBL] [Abstract][Full Text] [Related]
10. Preparation of influenza B virus recombinant strains.
Podchernyaeva RYa ; Shchipanova MV; Elkin VS; Melnichenko EI
Acta Virol; 1987 Nov; 31(6):475-80. PubMed ID: 2894141
[TBL] [Abstract][Full Text] [Related]
11. Location of ts defects in the genome of cold-adapted recombinant influenza A virus vaccine strains.
Medvedeva TE; Lisovskaya KV; Polezhaev FI; Garmashova LM; Alexandrova GI; Ghendon YZ
Acta Virol; 1984 May; 28(3):204-11. PubMed ID: 6147996
[TBL] [Abstract][Full Text] [Related]
12. Properties of A/Victoria/3/75 recombinants: development of an attenuated strain RIT 4050.
Lobmann M; Delem A; Jovanović D
Dev Biol Stand; 1977 Jun 1-3; 39():43-6. PubMed ID: 604127
[TBL] [Abstract][Full Text] [Related]
13. [Cold-adapted strain of A/Leningrad/134/47/57 (H2N2)--a special attenuation donor of live influenza vaccine for children and the isolation of its recombinants].
Garmashova LM; Polezhaev FI; Aleksandrova GI
Vopr Virusol; 1984; 29(1):28-31. PubMed ID: 6710978
[TBL] [Abstract][Full Text] [Related]
14. Analysis of genome composition and reactogenicity of recombinants of cold-adapted and virulent virus strains.
Ghendon YZ; Klimov AI; Alexandrova GI; Polezhaev FI
J Gen Virol; 1981 Apr; 53(Pt 2):215-24. PubMed ID: 7264609
[TBL] [Abstract][Full Text] [Related]
15. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
16. Studies on influenza-virus virulence in recombinants between epidemic and vaccine strains.
Zazimko LA; Vakin VS; Sklyanskaya EI; Zhdanov VM
Acta Virol; 1987 Sep; 31(5):387-96. PubMed ID: 2891277
[TBL] [Abstract][Full Text] [Related]
17. [Molecular genetic analysis of a cold-adapted donor attenuation strain for a pediatric liver influenza vaccine, of recombinants based on it and of isolates from vaccinated children].
Gendon IuZ; Klimov AI; Lisovskaia KV; Aleksandrova GI; Medvedeva TI
Vopr Virusol; 1984; 29(1):22-8. PubMed ID: 6710977
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a cold-recombinant influenza virus vaccine in ferrets.
Maassab HF; Kendal AP; Abrams GD; Monto AS
J Infect Dis; 1982 Dec; 146(6):780-90. PubMed ID: 7142749
[TBL] [Abstract][Full Text] [Related]
19. [Testing of influenza virus vaccines--an international comparison].
Klett G; Stäber H; Willkommen H
Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
[No Abstract] [Full Text] [Related]
20. [Optimal temperature of enzyme activity and heat resistance of neuraminidases as attenuation markers for influenza viruses].
Profeta ML; Ferrante P; Kotseva R
Boll Ist Sieroter Milan; 1977 Nov; 56(5):410-7. PubMed ID: 597391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
